UNIVERSITY OF FLORIDA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2) is a funding opportunity from UNIVERSITY OF FLORIDA, up to 538891, closing June 30, 2028.
Jun 30, 2028
(700d left)Overview
Due in part to recent advances in screening and treatment, the 5-year relative survival rate for patients with early-stage non-small cell lung cancer (NSCLC), the leading cause of cancer death worldwide, continues to increase each year. The uptake of guideline-recommended computed tomography (CT) imaging surveillance…